Human Foamy Virus: An Underestimated Neuropathogen?
暂无分享,去创建一个
E. Wagner | A. Aguzzi | A. Rethwilm | I. Horak | K. Bothe
[1] H. Zentgraf,et al. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. , 1991, Virology.
[2] A. Aguzzi,et al. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes , 1991 .
[3] S. Prusiner,et al. Molecular Biology and Pathology of Scrapie and the Prion Diseases of Humans , 1991, Brain pathology.
[4] B. Cullen,et al. Characterization of the transcriptional trans activator of human foamy retrovirus , 1991, Journal of virology.
[5] Herbert Budka,et al. Neuropathology of Human Immunodeficiency Virus Infection , 1991, Brain pathology.
[6] A. Ades,et al. Children born to women with HIV-1 infection: natural history and risk of transmission , 1991, The Lancet.
[7] V. ter meulen,et al. The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Flügel,et al. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures , 1991, Journal of virology.
[9] E. Wagner. EMBO medal review. On transferring genes into stem cells and mice. , 1990, The EMBO journal.
[10] B. Cullen,et al. Functions of the auxiliary gene products of the human immunodeficiency virus type 1. , 1990, Virology.
[11] P. Luciw,et al. Simian foamy virus type 1 is a retrovirus which encodes a transcriptional transactivator , 1990, Journal of virology.
[12] R. Jaenisch,et al. Role of abortive retroviral infection of neurons in spongiform CNS degeneration , 1990, Nature.
[13] J. Hauw,et al. Neuropathology of the acquired immunodeficiency syndrome. , 1990, Archives of pathology & laboratory medicine.
[14] E. Wagner,et al. Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. , 1990, The New biologist.
[15] J. Nelson,et al. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses , 1990, The Lancet.
[16] P. Luciw,et al. Relationship of the env genes and the endonuclease domain of the pol genes of simian foamy virus type 1 and human foamy virus , 1990, Journal of virology.
[17] D. Hanahan,et al. Transgenic mice as probes into complex systems. , 1989, Science.
[18] M. Nerenberg,et al. Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice. , 1989, The American journal of pathology.
[19] Stephen J. DeArmond,et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.
[20] S. Hinrichs,et al. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice , 1989, Nature.
[21] J. Leonard,et al. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. , 1988, Science.
[22] R. L. Davis,et al. NEUROPATHOLOGY OF ACQUIRED IMMUNODEFICIENCY SYNDROME , 1988, Neuropathology and applied neurobiology.
[23] R. Weiss. A virus in search of a disease , 1988, Nature.
[24] R. Flügel,et al. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus , 1988, Journal of virology.
[25] R. Flügel,et al. The 3′‐orf protein of human immunodeficiency virus 2 shows sequence homology with the bel3 gene of the human spumaretrovirus , 1987, FEBS letters.
[26] R. K. Reynolds,et al. A transgenic mouse model for human neurofibromatosis. , 1987, Science.
[27] R. Flügel,et al. Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. , 1987, The EMBO journal.
[28] B. Navia,et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.
[29] C. Gardell. Comparative Diagnosis of Viral Diseases , 1982 .
[30] M. Epstein,et al. The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. , 1980, The Journal of general virology.
[31] H. Gelderblom,et al. ISOLATION OF FOAMY VIRUS FROM PATIENTS WITH DE QUERVAIN THYROIDITIS , 1979, The Lancet.
[32] S. Birchall,et al. ISOLATION OF FOAMY VIRUS FROM PATIENT WITH DIALYSIS ENCEPHALOPATHY , 1978, The Lancet.
[33] M. Epstein,et al. An unusual virus in cultures from a human nasopharyngeal carcinoma. , 1971, Journal of the National Cancer Institute.
[34] M. Epstein,et al. A new human virus in cultures from a nasopharyngeal carcinoma. , 1971, Journal of Pathology.
[35] C. Rosen,et al. Regulation of HIV gene expression by RNA-protein interactions. , 1991, Trends in genetics : TIG.
[36] A. Aguzzi,et al. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. , 1991, Science.
[37] R. Vigne,et al. [Neurotoxicity in mice due to cysteine-rich parts of visna virus and HIV-1 Tat proteins]. , 1990, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[38] E. Wagner. On transferring genes into stem cells and mice. , 1990 .
[39] E. Wagner. Oncogenes and Transgenic Mice , 1990 .
[40] R. Weiss. Foamy retroviruses. A virus in search of a disease. , 1988, Nature.
[41] R. Flügel,et al. Molecular cloning of the genome of human spumaretrovirus. , 1987, Gene.
[42] F. Matsuura,et al. Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. , 1980, Intervirology.